Stay updated on Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial

Sign up to get notified when there's something new on the Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    0.5%
    Check dated 2025-07-03T12:25:55.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.4%
    Check dated 2025-06-19T02:28:56.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-11T20:25:24.000Z thumbnail image
  5. Check
    32 days ago
    No Change Detected
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.6%
    Check dated 2025-05-28T13:17:42.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T00:16:02.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed study information regarding the efficacy and safety of evobrutinib compared to teriflunomide for treating Relapsing Multiple Sclerosis, while adding a new revision number and collaborators.
    Difference
    9%
    Check dated 2025-04-22T18:13:24.000Z thumbnail image

Stay in the know with updates to Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial page.